Abstract

Methotrexate forms an inclusion complex with β-cyclodextrin (β-CyD) by a neutralization method. The formation of the inclusion complex was studied by phase solubility, X-ray diffractometry, differential scanning calorimetry and infrared spectroscopy. The amino group of methotrexate interacted with the hydroxyl function of β-CyD on complexation. The in-vitro drug release from the complex in phosphate buffer, pH 7–2, was better than that of the plain drug and other preparations evaluated. The complex had better bioavailability and showed better antitumour efficacy than methotrexate alone.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.